News

Last updated: 4 june, 2010 - 12:45 GMT

'Female viagra' to be discussed by US Food and Drug Administration

Bottle of pills

Flibanserin goes to the US Food and Drug Administration on 18 June

A new drug which affects sexual desire in women is to go before the body that regulates medicines in the United States later this month.

Flibanserin was initially trialled as an antidepressant but it produced the side effect of increasing female sexual desire, so the German pharmaceutical company that makes it wants to market it as a drug for sexual disorders.

Liz Canner is a documentary film maker who has been studying issues surrounding female sexual disorder for the last 10 years.

Dr Franklin Lowe is Professor of Clinical Urology at Columbia University.

He has worked as a consultant for Boehringer Ingelheim Pharmaceuticals, the company behind the drug.

To play this content JavaScript must be turned on and the latest Flash player installed.

Play in either Real OR Windows Media players

First broadcast 3 June 2010

related bbc links

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.